eLeaP expands QMS support for ISO 13485 medical device makers

3 hours ago
By AI, Created 13:00 UTC, Sep 07, 2026, AGP -

eLeaP said its QMS platform now has expanded support for medical device manufacturers seeking or maintaining ISO 13485:2016 certification. The update comes as the FDA’s new QMSR rule folds ISO 13485 into U.S. requirements, raising the stakes for traceability, document control and training records.

Why it matters: - Medical device makers now have to show compliance with ISO 13485:2016 directly under the FDA’s Quality Management System Regulation, making audit-ready quality records more important in the U.S. market. - eLeaP QMS is built to connect quality workflows and training verification in one system, which can reduce gaps that auditors often flag when records live in separate tools. - The platform is aimed at organizations that need one system of record across U.S. and international requirements, including QMSR, EU MDR and electronic signature rules.

What happened: - eLeaP announced expanded support in its eLeaP QMS platform for organizations pursuing or maintaining ISO 13485 certification. - The company said the capabilities are already used inside its integrated Quality Management System and Enterprise Learning Management System. - The platform is available now for medical device, digital health and Software as a Medical Device organizations. - Organizations can request a free demo.

The details: - ISO 13485 is the international quality standard for the design, development, production and servicing of medical devices. - The latest ISO Survey recorded 31,215 valid ISO 13485:2016 certificates worldwide across 43,957 sites. - ISO 13485 also underpins the Medical Device Single Audit Program, which allows manufacturers to satisfy quality-system requirements in the United States, Canada, Brazil, Japan and Australia through one audit instead of five. - The FDA’s QMSR took effect on February 2, 2026, and amended 21 CFR Part 820 to incorporate ISO 13485:2016 by reference. - eLeaP said its Design & Development module manages devices from concept through commercialization with traceability across requirements, specifications, verification and validation. - The same module automatically cascades training requirements to affected engineers and technicians when specifications change. - Document Control provides version control, approval workflows and effective dating. - Approved documents automatically trigger required retraining. - Supplier Management covers vendor qualification, audits and certificate tracking. - eLeaP mapped its modules to key ISO 13485 clauses: Design & Development to Clause 7.3, Document Control to Clauses 4.2.4 and 4.2.5, Supplier Management to Clause 7.4, and CAPA to Clauses 8.5.2 and 8.5.3. - The company said ISO 13485:2016 requires documented procedures for those clauses, not just described processes. - The broader eQMS suite also includes Risk Management, Change Control, CAPA, Event Management and Training Management. - eLeaP said the platform supports QMSR, 21 CFR Part 11 electronic signatures and EU MDR. - eLeaP has served regulated industries for more than 20 years and says it has worked with more than 1,200 regulated companies. - More information is available on the company’s website.

Between the lines: - The update reflects a broader shift in medical device compliance from separate quality and training systems toward connected workflows that can produce audit evidence automatically. - The FDA’s move to reference ISO 13485 directly makes software that links document control, design change and training records more relevant to manufacturers trying to avoid nonconformities. - eLeaP is positioning its QMS as a compliance hub rather than a standalone records system.

What’s next: - Medical device manufacturers adopting or renewing ISO 13485 certification may look for systems that tie quality actions to training documentation before audits. - eLeaP said the product is ready for immediate use, suggesting the company is targeting organizations facing the new FDA-aligned compliance environment now. - The company is also likely to market the same platform to adjacent regulated sectors that need similar traceability and document control.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.